Heart Test Laboratories (NASDAQ:HSCS) Trading Down 10.9% – Here’s What Happened

Heart Test Laboratories, Inc. (NASDAQ:HSCS)’s stock price traded down 10.9% during mid-day trading on Thursday . The company traded as low as $3.14 and last traded at $3.18. 34,292 shares were traded during mid-day trading, a decline of 77% from the average session volume of 152,124 shares. The stock had previously closed at $3.57.

Analysts Set New Price Targets

Separately, Ascendiant Capital Markets reissued a “buy” rating and issued a $15.00 target price on shares of Heart Test Laboratories in a research report on Monday, September 23rd.

Heart Test Laboratories Stock Up 11.9 %

The company has a quick ratio of 4.02, a current ratio of 4.49 and a debt-to-equity ratio of 0.08. The stock has a 50-day simple moving average of $3.55 and a 200-day simple moving average of $5.54. The firm has a market capitalization of $2.34 million, a PE ratio of -0.07 and a beta of 3.16.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.